Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06670911 |
| Title | Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer. (ACCESS-I) |
| Acronym | ACCESS-I |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Instituto Nacional de Cancer, Brazil |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | BRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Instituto Nacional de Cancer | RECRUITING | Rio de Janeiro | RJ | 20231050 | Brazil | Details |